KL and major depressive disorder: In the treatment of late-life MDD, patients who carry Klotho genetic polymorphism KL-VS (rs9536314) homozygotes respond poorly to selective serotonin reuptake inhibitors (SSRIs) compared to non-carriers after 6 months of treatment (22).